MAM
ALDX icon

Meeder Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History

Meeder Asset Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,043
Closed -$3K – 2024
2020
Q1 		$3K Sell
1,043
-5,352
-84% -$24.1K ﹤0.01% 1925
2019
Q4 		$38K Sell
6,395
-4,053
-39% -$23.4K ﹤0.01% 1111
2019
Q3 		$54K Buy
10,448
+9,489
+989% +$51.1K ﹤0.01% 990
2019
Q2 		$6K Sell
959
-8,326
-90% -$62.7K ﹤0.01% 1596
2019
Q1 		$84K Buy
9,285
+397
+4% +$3.37K 0.01% 742
2018
Q4 		$74K Buy
8,888
+4,822
+119% +$49.4K 0.01% 719
2018
Q3 		$56K Buy
+4,066
New +$33K ﹤0.01% 757

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meeder Asset Management's ALDX Position: Q2 2020 in Review

Meeder Asset Management sold out of Aldeyra Therapeutics (ALDX) in Q2 2020, closing a stake of 1,043 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in ALDX in Q3 2018 and held it in 7 quarters. The position peaked at $84K in Q1 2019. 84 funds tracked by Wall St. Rank hold ALDX as of Q2 2020.

  • Meeder Asset Management reported no remaining Aldeyra Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 1,043 Aldeyra Therapeutics shares in Q2 2020, an estimated $3K.
  • Meeder Asset Management first reported a position in Aldeyra Therapeutics in Q3 2018 and held it in 7 quarters.
  • Meeder Asset Management's Aldeyra Therapeutics position peaked at $84K in Q1 2019.
  • 84 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.